| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $59,562,079 ) (Continued on the next page) |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160570 | Hydrogen Sulfide in Neonatal Airway Disease | 000 | 2 | NIH | 11/13/2023 | $536,787 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21AR082134 | PHLPP inhibition and Osteoarthritis-Associated Pain | 000 | 2 | NIH | 12/7/2023 | $157,410 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA271503 | Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma | 000 | 2 | NIH | 12/29/2023 | $485,587 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB033008 | Development of an ultrasound detectable, migration-resistant biopsy marker for improving care in patients with breast cancer | 000 | 2 | NIH | 12/1/2023 | $576,204 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG076636 | Advancing MR elastography to map mechanical signatures of key AD/ADRD processes | 000 | 2 | NIH | 11/7/2023 | $397,775 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB031790 | Super Resolution for Improved Multislice Prostate MRI | 000 | 3 | NIH | 3/21/2024 | $505,357 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS126227 | Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep Phenotyping | 000 | 3 | NIH | 1/20/2024 | $357,750 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM144351 | Methods for microbiome compositional data | 000 | 3 | NIH | 12/22/2023 | $295,073 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NR020362 | SCH: Wearable Augmented Prediction of Burnout in Nurses: A Synergy of Engineering, Bioethics, Nursing | 000 | 3 | NIH | 1/30/2024 | $119,999 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NR020362 | SCH: Wearable Augmented Prediction of Burnout in Nurses: A Synergy of Engineering, Bioethics, Nursing | 000 | 3 | NIH | 1/30/2024 | $150,000 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA266344 | Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines | 001 | 3 | NIH | 12/15/2023 | $568,795 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | UG3NS123066 | Optimizing Pharmacotherapy with Noninvasive Wearable Sensors and Subscalp EEG | 000 | 2 | NIH | 3/25/2024 | $554,559 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG076515 | Defining the interactions of senescent immune cells and skeletal cells | 000 | 3 | NIH | 3/12/2024 | $428,154 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG076469 | A novel cilium-to-nucleus axis promotes cellular senescence | 001 | 3 | NIH | 2/21/2024 | $293,355 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160761 | Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology | 000 | 3 | NIH | 11/28/2023 | $571,997 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R61NS122096 | Intracranial D-2-Hydroxyglutarate as a Monitoring Biomarker for IDH-mutant Glioma. | 000 | 3 | NIH | 2/15/2024 | $357,750 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R35GM143949 | Fundamental and applied studies of nucleic acids | 000 | 3 | NIH | 1/23/2024 | $357,750 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG076163 | Regulation of the lymphoid cell fate by Hoxa9 | 000 | 3 | NIH | 12/8/2023 | $286,200 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK131685 | Noninvasive assessment of detrusor pressure and dysfunction | 000 | 3 | NIH | 1/22/2024 | $560,467 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AI162678 | Context dependent amino acid availability and sensing determines humoral immunity | 000 | 3 | NIH | 12/5/2023 | $423,745 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK127978 | Hepatic Steatosis Quantification with Ultrasound | 000 | 3 | NIH | 3/19/2024 | $449,550 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK130331 | Lipid metabolism and adipose tissue function | 000 | 3 | NIH | 11/29/2023 | $454,414 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | F31CA271560 | Defining Antigen-Dependent and Antigen-Independent Mechanisms for EGFRviii-Expressing Tumor Escape From Therapy | 000 | 3 | NIH | 2/13/2024 | $47,694 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K08AR078254 | The Role of Mitochondria in Inclusion Body Myositis | 000 | 3 | NIH | 3/12/2024 | $867 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AA029258 | Astrocyte-Neuron Interaction in the Dorsal Striatum and Ethanol-Seeking Behaviors Diversity supplement - Matthew Lopez | 001 | 4 | NIH | 3/26/2024 | $131,738 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AA029258 | Astrocyte-Neuron Interaction in the Dorsal Striatum and Ethanol-Seeking Behaviors Diversity supplement - Matthew Lopez | 000 | 4 | NIH | 2/24/2024 | $321,975 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K23MD016230 | Rural Patient Risks and Exposures for Diabetes ConTrol (Rural PREDICT) | 000 | 4 | NIH | 2/9/2024 | $147,258 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL157984 | Impact of Airway Inflammation on Mitochondria | 000 | 4 | NIH | 2/27/2024 | $615,352 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG071686 | Systemic Cell Senescence as a Mediator of Brain Aging Through Circulation | 000 | 4 | NIH | 2/12/2024 | $428,918 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | U01AI179609 | Mitochondrial Malfunction in T Cell Aging and Tissue Inflammation | 000 | 1 | NIH | 2/29/2024 | $581,040 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | U01AI179609 | Mitochondrial Malfunction in T Cell Aging and Tissue Inflammation | 001 | 1 | NIH | 3/4/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA285345 | Mechanism and therapeutic targeting of castration resistance in SPOP-mutated prostate cancer | 000 | 1 | NIH | 3/15/2024 | $507,395 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | F31HD112161 | Evaluating the mechanisms of cell free fetal DNA signaling in the promotion of labor | 000 | 1 | NIH | 2/28/2024 | $47,694 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK137231 | Engineering microcapsules for scalable differentiation of human pluripotent stem cells into hepatocytes | 000 | 1 | NIH | 2/29/2024 | $571,063 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21AI178147 | Role of the CX3CL1-CX3CR1 signaling axis in IPMN | 000 | 1 | NIH | 3/1/2024 | $217,890 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K99HL171911 | The role of proteoglycans in Heparin-induced thrombocytopenia: Implications for pathophysiology, diagnosis and treatment | 000 | 1 | NIH | 1/11/2024 | $165,780 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K08CA279652 | Elucidating the role of IRF4 in reprogramming the tumor microenvironment in follicular lymphoma | 000 | 1 | NIH | 1/10/2024 | $178,069 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R13AR084329 | ORS Tendon Conference 2024: Mechanism to Therapy ? Emerging Technologies and Therapeutic Outcomes | 000 | 1 | NIH | 3/20/2024 | $15,000 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21CA282702 | Clonal growth and prediction of monoclonal B-cell lymphocytosis | 000 | 1 | NIH | 3/20/2024 | $245,120 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21CA286349 | Characterization and treatment of a novel model of radiation optic neuropathy using the tree shrew | 000 | 1 | NIH | 1/23/2024 | $226,364 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG069052 | "What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias | 000 | 2 | NIH | 3/6/2024 | $706,566 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK136208 | Inhibition of autoimmune diabetes by ST8Sia6 | 000 | 1 | NIH | 2/12/2024 | $454,682 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21AI181542 | The Role of the EphA2 Receptor Kinase Pathway in Pneumocystis Pneumonia (PCP) | 000 | 1 | NIH | 11/16/2023 | $217,890 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01MH131623 | Uncovering the origin of hypermutability in adult brains | 000 | 1 | NIH | 11/15/2023 | $814,313 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG081955 | Validation of the Mayo Test Drive Screening Battery Composite and Stricker Learning Span for Early Detection and Monitoring of Cognitive Decline in Preclinical and Prodromal Alzheimer?s Disease | 000 | 1 | NIH | 11/16/2023 | $1,453,969 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL171056 | INTEGRATION OF MECHANICAL AND MOLECULAR CUES DURING DISTAL LUNG DEVELOPMENT | 000 | 1 | NIH | 1/26/2024 | $547,614 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | F31CA287495 | DUSP2 in Negative Regulation of Cytotoxic T Cell Responses to Immunotherapy | 000 | 1 | NIH | 1/26/2024 | $47,694 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R03CA289560 | Refinement of a Training Module to Improve Discussions of Sexual Orientation and Gender Identity in Cancer Clinics | 000 | 1 | NIH | 3/25/2024 | $80,700 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK134448 | NAFLD Diagnosis and Outcomes | 000 | 1 | NIH | 2/14/2024 | $530,351 |
|